Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors

被引:0
|
作者
Bromberg, Kenneth D. [1 ]
Lasko, Loren M. [1 ]
Jakob, Clarissa G. [1 ]
Qiu, Wei [1 ]
Montgomery, Debra [1 ]
Digiammarino, Enrico L. [1 ]
Hansen, Todd M. [1 ]
Risi, Roberto M. [1 ]
Frey, Robin R. [1 ]
Manaves, Vlasios [1 ]
Shaw, Bailin [1 ]
Algire, Mikkel [1 ]
Hessler, Paul [1 ]
Lam, Lloyd T. [1 ]
Uziel, Tamar [1 ]
Favire, Emily [1 ]
Ferguson, Debra [1 ]
Buchanan, Fritz G. [1 ]
Martin, Ruth L. [1 ]
Torrent, Maricel [1 ]
Rosenberg, Saul H. [1 ]
Michaelides, Michael R. [1 ]
Lai, Albert [1 ]
机构
[1] AbbVie Inc, N Chicago, IL USA
关键词
D O I
10.1158/1535-7163.TARG-17-LB-A23
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-A23
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
    Valor, Luis M.
    Viosca, Jose
    Lopez-Atalaya, Jose P.
    Barco, Angel
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (28) : 5051 - 5064
  • [22] Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
    Brennan, P.E. (paul.brennan@sgc.ox.ac.uk), 1600, American Chemical Society (136):
  • [23] Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
    Hay, Duncan A.
    Fedorov, Oleg
    Martin, Sarah
    Singleton, Dean C.
    Tallant, Cynthia
    Wells, Christopher
    Picaud, Sarah
    Philpott, Martin
    Monteiro, Octovia P.
    Rogers, Catherine M.
    Conway, Stuart J.
    Rooney, Timothy P. C.
    Tumber, Anthony
    Yapp, Clarence
    Filippakopoulos, Panagis
    Bunnage, Mark E.
    Mueller, Susanne
    Knapp, Stefan
    Schofield, Christopher J.
    Brennan, Paul E.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (26) : 9308 - 9319
  • [24] Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases
    Ji, Zhiqin
    Clark, Richard F.
    Bhat, Vikram
    Hansen, T. Matthew
    Lasko, Loren M.
    Bromberg, Kenneth D.
    Manaves, Vlasios
    Algire, Mikkel
    Martin, Ruth
    Qiu, Wei
    Torrent, Maricel
    Jakob, Clarissa G.
    Liu, Hong
    Cole, Philip A.
    Marmorstein, Ronen
    Kesicki, Edward A.
    Lai, Albert
    Michaelides, Michael R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 39
  • [25] Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
    Chang, Qi
    Li, Jiayi
    Deng, Yue
    Zhou, Ruilin
    Wang, Bingwei
    Wang, Yujie
    Zhang, Mingming
    Huang, Xun
    Li, Yingxia
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (04) : 2466 - 2486
  • [26] Preclinical Safety Assessment of a Highly Selective and Potent Dual Small-Molecule Inhibitor of CBP/P300 in Rats and Dogs
    Katavolos, Paula
    Cain, Gary
    Farman, Cindy
    Romero, F. Anthony
    Magnuson, Steven
    Ly, Justin Q.
    Choo, Edna F.
    Katakam, Anand Kumar
    Andaya, Roxanne
    Maher, Jonathan
    TOXICOLOGIC PATHOLOGY, 2020, 48 (03) : 465 - 480
  • [27] Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer
    Ding, Hong
    Pei, Yuan
    Li, Yuanqing
    Xu, Wen
    Mei, Lianghe
    Hou, Zeng
    Guang, Yiman
    Cao, Liyuan
    Li, Peizhuo
    Cao, Haijing
    Bian, Jinlei
    Chen, Kaixian
    Luo, Cheng
    Zhou, Bing
    Zhang, Ting
    Li, Zhiyu
    Yang, Yaxi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 52
  • [28] FT-6876, a potent and selective inhibitor of CBP/p300 with antitumor activity in AR-positive breast cancer
    Caligiuri, Maureen
    Williams, Grace L.
    Castro, Jennifer
    Battalagine, Linda
    Muskiewicz, Kristina
    Wilker, Erik
    Yao, Lili
    Schiller, Shawn
    Toms, Angela
    Li, Ping
    Pardo, Eneida
    Graves, Bradford
    Wood, Kenneth W.
    Guichard, Sylvie M.
    CANCER RESEARCH, 2020, 80 (16)
  • [29] Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
    Hogg, Simon J.
    Motorna, Olga
    Cluse, Leonie A.
    Johanson, Timothy M.
    Coughlan, Hannah D.
    Raviram, Ramya
    Myers, Robert M.
    Costacurta, Matteo
    Todorovski, Izabela
    Pijpers, Lizzy
    Bjelosevic, Stefan
    Williams, Tobias
    Huskins, Shannon N.
    Kearney, Conor J.
    Devlin, Jennifer R.
    Fan, Zheng
    Jabbari, Jafar S.
    Martin, Ben P.
    Fareh, Mohamed
    Kelly, Madison J.
    Dupere-Richer, Daphne
    Sandow, Jarrod J.
    Feran, Breon
    Knight, Deborah
    Khong, Tiffany
    Spencer, Andrew
    Harrison, Simon J.
    Gregory, Gareth
    Wickramasinghe, Vihandha O.
    Webb, Andrew, I
    Taberlay, Phillippa C.
    Bromberg, Kenneth D.
    Lai, Albert
    Papenfuss, Anthony T.
    Smyth, Gordon K.
    Allan, Rhys S.
    Licht, Jonathan D.
    Landau, Dan A.
    Abdel-Wahab, Omar
    Shortt, Jake
    Vervoort, Stephin J.
    Johnstone, Ricky W.
    MOLECULAR CELL, 2021, 81 (10) : 2183 - +
  • [30] Analysis of the p300/CBP-Associated Factor (PCAF) gene in astrocytic tumors
    Nishimori, H
    Nishikawa, R
    Fujimaki, T
    Nakagomi, T
    Matsutani, M
    Huang, HJS
    Cavenee, WK
    JOURNAL OF NEURO-ONCOLOGY, 2000, 46 (01) : 17 - 22